登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C10H19NO3
化学文摘社编号:
分子量:
201.26
UNSPSC Code:
12352209
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
3542667
assay
98%
form
solid
optical activity
[α]21/D −48°, c = 1.3 in chloroform
reaction suitability
reaction type: Boc solid-phase peptide synthesis
mp
62-64 °C (lit.)
application(s)
peptide synthesis
SMILES string
CC(C)(C)OC(=O)N1CCC[C@H]1CO
InChI
1S/C10H19NO3/c1-10(2,3)14-9(13)11-6-4-5-8(11)7-12/h8,12H,4-7H2,1-3H3/t8-/m0/s1
InChI key
BFFLLBPMZCIGRM-QMMMGPOBSA-N
Application
用于新型烟碱型乙酰胆碱受体配体(具有强化识别性)的结构单元。用于合成手性 β-氨基硫醚和 β-氨基硫醇。
用于合成抗凝剂。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
Elliott, R.L. et al.
Bioorganic & Medicinal Chemistry Letters, 6, 2283-2283 (1996)
Satoshi Komoriya et al.
Bioorganic & medicinal chemistry, 12(9), 2099-2114 (2004-04-15)
Since factor Xa (fXa) plays a pivotal role in the blood coagulation cascade, inhibition of fXa is thought to be an effective treatment for a variety of thrombotic events. (2S)-2-[4-[[(3S)-1-Acetimidoyl-3-pyrrolidinyl]oxy]phenyl]-3-(7-amidino-2-naphthyl)propanoic acid hydrochloride pentahydrate (DX-9065a) was previously found in our laboratory
Cran, G.A. et al.
Tetrahedron Asymmetry, 6, 1553-1553 (1995)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 446327-1G | 04061826222164 |
| 446327-5G | 04061832642222 |